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Abstract
Cooling towers are possible sources of contamination to the environment, with
implications to human health. Cooling towers are known sources for disease outbreaks. The
cooling process releases aerosols, which if cooling towers are not adequately sanitized,
pathogenic bacteria may be released and contaminate the environment. Compounding the risk of
pathogenic bacteria release, cooling towers provide ideal conditions for biofilms to grow which
encourage the exchange of antibiotic resistance genes. Current sanitation methods are unable to
prevent or effectively remove biofilms in cooling towers. Therefore, a new sanitation method is
necessary. This research explores the feasibility of using electrical pulse generators (EPG)
manufactured by Environmental Energy Technologies Inc. (EET) to disinfect cooling tower
water. This sanitation method constantly lyses bacterial cells by sending pulsed electrical fields
(PEF) through the water. EET has developed a standard EPG (STD EPG) that is currently in use
and an experimental EPG (EXP EPG) that is a purportedly improved version of the STD EPG.
The purpose of this study was to determine if the EXP EPG was more effective than the STD
EPG to sanitize cooling towers through evaluating the microbial CFUs/ ml and diversity. Water
samples from each EPG treatment were collected from several building installation on the
Rochester Institute of Technology (RIT) campus. These were examined for microbial richness,
diversity, antibiotic resistance, and identity using the 16S rRNA gene. The results of the study
suggest that there is antibiotic resistant bacteria present in cooling towers. In addition to this
seasonality impacted species diversity where the fall had a lower diversity than the summer.
Finally, it was determined the two EPG treatments both able to effectively sanitized cooling
towers, but it was indistinguishable which treatment was more effective.
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Chapter 1: Introduction and Literature Review
Introduction
Cooling towers are possible sources of contamination to the environment, with
implications to human health. Their purpose is to absorb and release heat from air conditioning,
industrial, and power generation processes (Engelhart et al., 2008). They function in counter
current systems where cool water from the cooling tower basin absorbs heat from heat
exchangers. Then, the water is cooled through evaporative cooling and collects in the basin to b
recirculated. However, when the water returns to the basin, it contains a higher concentration of
inorganic and organic material (Kurtz et al., 1982). As a result, cooling towers create an
environment where bacteria can thrive. Thriving bacterial communities can result in the
development of biofilms, which are difficult to remove through current sanitation treatments
(Ozdemir and Ceyhan, 2010). Biofilms are also able to resist antibiotics and increase the chance
of genetic exchange of antibiotic resistance genes (Slonczewski and Foster, 2017; Balcázar et al.,
2015). Therefore, pathogens and antibiotic resistant bacteria may persist in cooling towers after
sanitation treatments in biofilms, thus these bacteria can be released into the environment and
cause contamination. Consequently, research addressing how to adequately disinfect cooling
towers to prevent biofilm formation is an emerging field of study.
Pulsed electrical fields (PEF) may be a superior method to disinfect cooling water as a
preventative treatment that does not result in harmful byproducts or electro-resistance in the
bacteria (Gusbeth et al., 2009). Therefore, I proposed to study the effectiveness of electronic
pulse generators (EPG) manufactured by Environmental Energy Technologies Inc. (EET). EPG
devices use a PEF to lyse bacterial cells, which reduces bacterial loads thus preventing biofilm
production and scale accumulation within cooling towers. In this study, I evaluated the standard
electronic pulse generator (STD EPG) that is currently used in the installations of EET and the
experimental electronic pulse generator (EXP EPG) which is a modification of the STD EPG to
be more efficient. Using water samples from each EPG treatment and examining microbial
colony-forming units/ ml (CFU/ml), diversity, and antibiotic resistance, this study evaluates how
effective these two EPG treatments are to sanitize cooling towers and prevent harmful bacteria
from contaminating the environment.
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Cooling Towers Function
Cooling towers are part of the heating, ventilation, and air conditioning (HVAC) systems
in buildings. Their purpose is to cool and hold water that is used to dissipate heat from heat
exchangers (Center for Disease Control, 2017). In the HVAC system, water from the cooling
tower, in the cooled state, is pumped out to absorb heat from heat exchangers. Once the water
has absorbed the heat, the water enters the top of the cooling tower to be cooled through
evaporative cooling. The warmed water is sprayed from the top of the tower onto a surface, such
as splash bars. Concurrently, atmospheric air interacts with the water and a fan blows air up and
out of the tower to increase cooling (Figure 1). Evaporative cooling releases heat from the
system and produces aerosols which are released into the environment through openings in the
tower. Finally, the cooled water collects at the base of the cooling tower to be recirculated (Kurtz
et al., 1982; Milosavljevic and Heikkilä, 2001). Although this process is effective in removing
heat, it also causes serious sanitation and contamination concerns because if pathogenic bacteria
are able to thrive they could easily be released as an aerosol and cause contamination.
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Figure 1: Schematic of cooling tower function (Kurtz et al., 1982).
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Biofilms and Bacteria in Cooling Towers
Bacteria in cooling towers can persist in the water as planktonic or sessile organisms,
however the majority are immobile bacteria in biofilm communities (Ozdemir and Ceyhan,
2010). Biofilms are accumulations of microorganisms, established on a surface, surrounded by
an extracellular matrix made up of polysaccharide polymers, DNA, proteins, and inorganic
materials (Slonczewski and Foster 2017). These form where nutrients and conditions are ideal
for growth because it is more efficient to be sessile than hunt for food (Slonczewski and Foster,
2017). Cooling towers provide these conditions due to their large surface areas, low water flow
speeds, and constant elevated temperature (Lin et al., 1998; Zacheus et al., 2000). The
evaporative cooling process increases the concentration of organic and inorganic materials in
water, which increases nutrients for bacteria, improving conditions for biofilm production (Kurtz
et al., 1982). Additionally, construction materials of cooling towers may provide growth
supporting factors. The leaching of biodegradable plasticizers can result in higher biomasses of
biofilms (Colbourne, 1985). Consequently, these common cooling tower conditions provide
habitat for bacteria to thrive and produce biofilms.
Biofilm formation poses many threats to cooling towers, the most pressing to this
research is their ability to be reservoirs of pathogens and resist removal through disinfection
(Ozdemir and Ceyhan, 2010; Wingender and Flemming, 2011). The exopolysaccharides of the
biofilm protect the bacteria from environmental conditions, antibiotics, and sanitation treatments
(Ozdemir and Ceyhan, 2010; Slonczewski and Foster 2017). Biofilms are able to resist sanitation
treatments, while the same planktonic cells cannot, due to the biofilm matrix which blocks the
inner channels of the biofilm structure and protects the dense aggregates of bacteria within the
biofilm (Ozdemir and Ceyhan, 2010). As a result, pathogenic bacteria can persist and even
multiply in biofilms. Then, when conditions are no longer ideal the bacteria may be released
from the biofilms and cause contamination to the cooling tower and subsequently the
environment through the evaporative cooling emissions (Wingender and Flemming, 2011).
Some known pathogens of concern in cooling towers are Legionella pneumophila and
Pseudomonas aeruginosa. L. pneumophila is a pathogen of concern for cooling towers which
causes Legionnaires Disease through inhaling the pathogen when aerosolized from the
evaporative cooling process. It also utilizes biofilms and parasitizes amoebae to support its

Saxena 19

growth. The parasitized amoebae and biofilm act as a protective environment around L.
pneumophila. It prevents L. pneumophila from being removed during sanitation treatments and
allows it to survive in conditions that are not ideal for the pathogen (Kuiper et al., 2004; Kurtz et
al., 1982; Yamamoto et al., 1992). P. aeruginosa is also a bacteria of concern since it can
synthesize biofilms in aquatic habitats, have amoebae associations, and produce biofilms in the
lungs of cystic fibrosis patients which can lead to death (Branda et al., 2005; Brown and Barker,
1999). In addition, Karami et al., (2020) found that biofilm formation of P. aeruginosa reduces
its antibiotic susceptibility. These bacterial interactions with biofilms and their ability to form
biofilms are an issue because although a sanitation treatment may be effective at removing
planktonic cells, the bacteria in biofilms are protected and can remain in the system (Ozdemir
and Ceyhan, 2010). Therefore, for sanitation treatments to be effective they must treat biofilms
or prevent biofilms from forming. The EPG treatments use mechanisms to prevent biofilms from
forming to avoid the issues biofilms cause.
Antibiotic Resistance in Cooling Towers
Biofilm formation not only resists disinfection but can increase the presence of antibiotic
resistant bacteria. The bacteria grown in a biofilm state may not be antibiotic resistant
genetically, but in this state the bacteria are less susceptible to the antibiotics (Anderl et al.,
2000). The biofilms may prevent antibiotics from affecting bacteria through several mechanisms.
The polysaccharide matrix of the biofilm prevent antibiotics from penetrating into the biofilm to
reach the bacteria, the bacterial cells may have a resistant phenotype, or the biofilm contains
cells that are either slowly growing, not growing, or living in a stress response due to
unfavorable conditions in the biofilm (Balcázar et al., 2015; Stewart, 2002; Stewart and
Costerton, 2001; Slonczewski and Foster, 2017). These mechanisms are linked to the presence of
antibiotic resistance genes (Anderl et al., 2000; Balcázar et al., 2015). Due to the close proximity
of bacteria in biofilms there is an increased chance of genetic exchange of antibiotic resistance
genes (Fux et al., 2005; Hausner and Wuertz, 1999; Li et al., 2002). Conjugation rates in biofilms
are faster and larger biofilm surface/volume ratios are correlated with higher gene transfer
efficiency (Hausner and Wuertz, 1999; Molin and Tolker-Nielsen, 2003). Consequently, since
cooling towers are hot spots for biofilms they also tend to be hot spots for antibiotic resistance.
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There is an enhanced risk to human health if there is a presence of antibiotic resistant pathogens
in cooling towers due to their ability to share resistance genes and be dispersed into the
environment as aerosols.
There are many different antibiotic classes that use different mechanisms to treat bacterial
infections. There are serious concerns for bacteria with multiple drug resistances. This study set
out to evaluate if there were antibiotic resistant bacteria in the planktonic bacterial community of
cooling towers, which could cause harm if released into the environment. The antibiotics in this
study span a broad spectrum of the antibacterial classes. In addition, they are common drugs
used in hospitals for bacterial infections (Coates et al., 2011; Whitburn, 2019). Therefore,
resistance to these antibiotics would be concerning because of their wide use.
Contamination to the Environment
The evaporative cooling process used by cooling towers to dissipate heat produces
aerosols and releases them into the surrounding environment. This process can contaminate the
environment when these aerosols contain pathogens or antibiotic resistant bacteria that were
present in the cooling tower water. Legionnaires Disease caused by L. pneumophila are the most
common illness borne from contaminated cooling towers. Outbreaks of this illness are well
documented and were used as a case study to explain how far pathogens aerosolized from
contaminated cooling towers can disperse disease. However this research did not focus on
detecting L. pneumophila. In the largest L. pneumophila outbreak in 2001, a person passing
through a 400 m radius of the contaminated cooling tower was very likely to contract
Legionnaires Disease (García-fulgueiras et al., 2003). L. pneumophila outbreaks have been
documented up to 3.4 km from contaminated cooling towers, indicating aerosolized pathogens
were able to travel that far and still cause infection (Sala Ferré et al., 2009). These large zones of
exposure put people who travel through them at severe risk of infection from pathogens cooling
towers are contaminated with. Therefore, continuous sanitation of cooling towers is necessary to
prevent this risk and protect public health.
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Current Sanitation Methods
According to Kurtz et al. (1982), sanitation methods should be effective in a vast range
of pH and temperatures, be fast, and inexpensive. The current sanitation methods attempt to
follow these guidelines, but other factors in cooling towers may influence them and render the
sanitation ineffective. Chlorination is the most widely used method of sanitation, however it has
limitations and drawbacks. High temperatures or pH, common conditions for cooling towers,
render chlorination ineffective (Tchobanoglous and Burton, 2002). Chlorination also has harmful
consequences such as corrosion of cooling tower infrastructure and interacting with organics
resulting in halogenated organics and carcinogens (Emmanuel et al., 2004; Lin et al., 1998).
Other sanitation methods are UV irradiation and ozone. Ozone is more often a supplemental
treatment with another disinfectant due to its rapid decomposition (Muraca et al., 1987). UV
irradiation requires a large UV light for the water to pass by. However, if the water is turbid light
cannot penetrate the water deep enough to effectively sanitize (Schwartz et al., 2003). Silvercopper ionization is a novel method of sanitation, which introduces electrically generated silver
and copper ions into the water line to kill bacteria, specifically L. pneumophila (Lin et al., 1998).
Unfortunately, an elevated pH can inactivate this method shifting the predominately positive
copper ions to negative ions, preventing the ions from binding to the cells to lyse the cells (Lin et
al., 2002). Consequently, all these sanitation methods are ineffective at consistently controlling
bacterial growth within cooling towers and cannot prevent the accumulation and attachment of
biofilms.
Electronic Pulse Generator (EPG)
The drawbacks of these current sanitation methods make the novel use of EPGs an
appealing solution (Figure 2). These function to reduce bacterial CFUs/ml in cooling tower
waters and prevent biofilm accumulation by continually sanitizing the cooling towers with short
electrical pulses. This method is based on electroporation which uses a low electrical field to
form pores in the lipid bilayer. Conventionally, these pores are reversible, where the membrane
can rebound around the cell and close up after the electrical field is removed (Joshi and
Schoenbach, 2000). Conventional electroporation is used for transfection to insert DNA,
biologically active molecules into cells and is a nonthermal way of killing microorganisms (Sale
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and Hamilton, 1967; Weaver and Chizmadzhev, 1996). The EPG uses this same concept, but
attempts to make a pore that results in cell lysis. It sends high voltage PEF through the water to
create pores in the cell membrane. The pulses in the electrical field increases the probability of
producing large pores or multiple pores that coalesce into large irreversible pores (Joshi and
Schoenbach, 2002). Irreversible pores prevent the cell membrane from rebounding around the
cell and cause cell lysis (Neumann and Rosenheck, 1972; Weaver and Chizmadzhev, 1996).
This novel sanitation method does not have the limitations of the current sanitation
methods. Short electrical pulses have negligible thermal heating, low power inputs with large
electrical fields, and time scales that can be adjusted for the pulse width. Additionally, multiple
high-intensity pulses are able to cause more irreversible damage than single-shot electrical pulses
(Joshi and Schoenbach, 2002). EPGs function to continually sanitizing the bulk water in the
basin of cooling towers. This method of continually sanitizing water prevents bacteria from
accumulating in the towers and developing biofilms. In comparison, the sanitation frequency for
chlorination is anywhere from every 18 hours to several times a week (Tsao et al., 2019). EPGs
are advantageous since they are unlikely to cause chemical modification of the water to change
the genotoxicity. Comparatively, the chlorination disinfection method changes the chemical
compounds to produce halogenated organic compounds (Emmanuel et al., 2004). Also, the
survival of bacteria after this treatment is not due to electro tolerance transferred from bacterial
descendants but rather an extreme bacteria feature. These features could be cell size, physiologic
state of the microorganism, and cytoplasmic chemical content during the treatment (Gusbeth et
al., 2009). As a result this method is able reduce bacterial population sizes, thus preventing them
from forming biofilms, with minimal limitations and side effects.
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Figure 2: EPG developed by EET.
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Other Applications of EPG
The use of EPGs on cooling tower sanitation is a novel method, but PEFs have been used
in other areas to kill bacteria cells. Al-Sakere et al. (2007) used the PEF method as a minimally
invasive way to treat tumors. In another study, PEFs were evaluated to sanitize hospital waste
water to as a potential alternative to chlorination and prevent halogenation of organics within the
waste water (Emmanuel et al., 2004). Finally, the most common use for PEFs is for
electroporation to insert materials into the cell (Weaver and Chizmadzhev, 1996).
Study Focus
This study used two EPG units developed by EET to sanitize cooling towers. We
evaluated the STD EPG unit EET uses for all their installations and an EXP EPG unit that has
been modified to be more effective than the STD EPG (Figure 3). These units both treat the
water with an electrical pulse, but with different pulse signals. The STD EPG has an exponential
decay function signal and the EXP EPG has a square wave signal, so the electrical pulse could
penetrate deeper into the water. The STD EPG with its exponential decay function signal allows
it to be used as a coil wrapped or skid-based system, while the EXP EPG can only be used as a
skid-based system interfaced with a cooling tower. EET will use this evaluation to determine if
the changes to the EXP EPG have improved the ability of EPGs to sanitize cooling towers.

Figure 3: EPG installations STD EPG on left, EXP EPG on right.
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Goals, Objectives, and Hypotheses
Goal: Prevent cooling towers from being a source of contamination and potential risk to public
health.
Objectives:
1. Determine which device is more effective at removing bacteria by comparing the
bacterial levels of the STD EPG to the EXP EPG.
Hypothesis: If the EXP EPG is effective, it will have lower bacterial CFUs compared to the
STD EPG.
2. Determine if microbial populations remaining in the water systems are of similar
diversity composition between the two treatments.
Hypothesis: If the EXP EPG is effective, it will have lower microbial diversity.
3. Determine abundance of antibiotic resistant bacteria in the water after treatment.
Hypothesis: The EXP EPG will have a lower presence of antibiotic resistant bacteria.
Chapter 2: Preliminary Methods and Results
This research was based off of findings from preliminary research. The first preliminary
methods were conducted from November 2018 to July 2019 on the Rochester campus of the
Rochester Institute of Technology (RIT). This period sampled three cooling towers within
building 2 (BLD 2) which was the Frank Ritter Ice Arena, building 14 (BLD 14) the Hugh L.
Carey Hall and building 76 (BLD 76) the Chester F. Carlson Center for Imaging Science. BLD
14 was treated with the EXP EPG, while BLD 2 and BLD 76 were treated with the STD EPG.
This method tested for fungi using SAB plates, antibiotic resistance using the Kirby-Bauer disc
diffusion method, and heterotrophic bacteria using Millipore HPC Red Test Samplers (HPC
Samplers) and R2A plates (Figure 4). The results found no fungi present and no substantial
difference between the EPG treatments. However, the heterotrophic bacteria below allowable
levels, less than 5 log CFUs (Monash University, 2017) (Figure 5). Additionally, antibiotic
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resistant bacteria was present in both EPG treatments (Figure 6). The antibiotics used in the
preliminary methods were the same antibiotics used in experimental methods. These findings
sparked a deeper study into antibiotic resistance of the cooling tower bacterial population and a
change in the EXP EPG pulse signal. Therefore in the 2020 sampling period the EXP EPG had
an increased pulse width as compared to the preliminary samplings.

Figure 4: Media used to test microbial enumeration R2A plates (top) HPC Samplers (bottom).
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Figure 5: HPC Samplers CFU/ml at 24 hour increments. 300 CFUs was the maximum number of bacteria

CFU/ml, bacteria values greater than this were those that were considered too numerous to count. BLD 2 and 76
had the STD EPG unit and BLD 14 had the EXP EPG unit.
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Figure 6: Antibiotic resistance levels of bacteria from BLD 14, BLD 76, and BLD 2. The
bacteria were identified by their colony color. All cooling towers had antibiotic resistant
bacteria and only one bacteria tested had no resistance to any of the 24 antibiotics tested.
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The second preliminary method utilized the new EXP EPG and a split treatment system.
This split system was equipped only on the cooling tower in BLD 14 because it was the only one
running in the winter from December 2019 to February 2020, when this sampling occurred. The
purpose of the split system was to test each EPG on the same cooling tower and remove
variability possibly caused by unique environmental conditions of each particular tower. The
split treatment system treated the water from the water basin in BLD 14 with both the STD and
EXP EPG (Figure 7). Therefore, each EPG unit took a sample of the water, treated it, and
returned it to bulk water in the tower. A sample was taken from each EPG unit immediately after
treatment and tested for fungi, heterotrophic bacteria, and antibiotic resistance using the same
methods as the first preliminary method.
The results of this second preliminary method continued to show the EPG treatments had
very similar bacterial CFUs/ml (Figure 8, 9). This was attributed to the fact that after treatment
by each unit, the water was replaced into the same basin. Additionally, even though samples
were taken immediately after the EPG treatment there was likely not enough reaction time to
isolate each particular treatment to compare their efficiency. Consequently, the mixing of the two
treatments in the bulk water caused the samples EPG treatments to appear very similar. The
Millipore Yeast and Mold Yellow Test Samplers consistently had little to no growth, indicating
no presence of fungi in these cooling towers. Antibiotic resistance was also reported in these
samples (Figure 10). Therefore this second method proved the split system was inadequate to
isolate the each EPG treatment, and further confirmed the lack of fungi present in the cooling
towers.
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Figure 7: Split system treatment. Water in the collection basin is treated in one of the EPG units and
returned to the collection basin (Edreher at English Wikipedia and Zerodamage, 2012). A modification
was made to this image.
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Figure 8: Split system 2019-2020 R2A Plates heterotrophic bacteria results for the STD and EXP
EPG at 24hr increments. *lack of bars indicates CFU/ml of bacteria that were too numerous to
CFU/ml.
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Figure 9: HPC Samplers results using the split system from 2019-2020. Graph represents the
STD and EXP EPG CFUs at 24hr increments. *lack of bars indicates CFU/ml of bacteria that
were too numerous to CFU/ml.

80%

% Antibiotic Resistance

70%
60%
50%
40%
30%
20%
10%
0%
STD EPG White 1
mm

EXP EPG Yellow

STD EPG Red

STD EPG White 3 STD EPG White 50
mm
mm

Bacteria

Figure 10: Antibiotic resistance in the split system 2019-2020. Bacteria had 4%-75% antibiotic
resistance sparking that further study of antibiotic resistant bacteria in cooling towers.
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Chapter 3: Experimental Methods
Sampling Sites
Sampling sites were chosen from RIT’s Rochester campus due to their indoor and
outdoor connecting cooling towers within a two mile square area to decrease variation in
environmental conditions between cooling towers. BLD 2, the Frank Ritter Ice Arena was
sampled from during the preliminary data collection period and was an indoor cooling tower
equipped with the STD EPG. The cooling tower within BLD 14, Hugh L. Carey Hall, was
selected because it was an indoor cooling tower thus only the cooling tower fills were exposed to
the outside environment and this tower was functional all year round. BLD 14 was equipped with
the EXP EPG since 2018, therefore was able to show how the EPG performs over a long period
of time to reduce bacteria growth. From 2018-2019 the EXP EPG pulse signal was a square
wave (step function) signal, preliminary data determined this signal did not improve the EXP
EPG performance more than the STD EPG. As a result, the EXP EPG’s pulse width was
increased and this adjusted EXP EPG was used for the 2020 sampling period starting in July.
The cooling tower in BLD 76, the Chester F. Carlson Center for Imaging Science, had the STD
EPG unit installed and was used as a control. BLD 76 was a seasonally functional cooling tower
from late spring to late fall. It had an outdoor connection such that the cooling tower fills and
water basin of the cooling tower were exposed to the outside environment.
2020 Sample Collection
In the summer and fall of 2020 (the 2020 sampling period) water samples were collected
from BLD 14 and BLD 76. The STD EPG unit in BLD 76 was sampled the entire time it was
functional. The EXP EPG unit in BLD 14 was sampled from July to September, then the EXP
EPG was turned off and replaced by the STD EPG unit which was sampled from October to
December. At each site three, 300 ml samples of water were collected immediately after
treatment every two weeks. Then, the samples were placed on ice and refrigerated at 4℃ until
analyzed (Figure 11). Samples were viable for 2 weeks, but analysis occurred as soon as
possible, most frequently on the same day of collection.
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Figure 11: Field sampling materials included water collection containers and a cooler filled with
ice for transport.
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Microbial Enumeration
The microbial population of the water samples were tested for bacteria using nutrient
agar and HPC Samplers. The HPC Samplers were used according to manufacturer's instructions.
The indicated amount of sample water was poured into the container and the agar paddle was
inserted into the water for 30 seconds. Then, the water was drained from the container and the
HPC Samplers incubated for 3 days with bacteria counts taken every 24 hours (MilliporeSigma,
2019) (Figure 14). If the number of colonies on the HPC Samplers were too numerous to count
after 24 hours, the samples were tested again with a 10 -1 dilution using distilled water. These
HPC Samplers are what the industry uses to enumerate bacterial CFU/ml of cooling towers.
The nutrient agar used for bacterial enumerations were R2A and PCA plates. R2A are the
media recommended by the Center for Disease Control for water samples (Center for Disease
Control, 2015). PCA plates are approved by the Public Health Association, Water Environmental
Federation, and American Water Works Association for growing water sample bacteria (Baird et
al., 2017). For this method, 0.1 ml of sample was serially diluted (10 -2 to 10-4) with NaCl (Kim et
al., 2004) (Figure 12). Then, 0.1 ml of the sample and the dilutions were spread on the nutrient
agar plates and incubated at 30 ℃ (Figure 13). Bacterial counts were taken every 24 hours for 3
days (Figure 14).
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Figure 12: Serial dilutions performed. Tubes contain 9 ml of 0.9% NaCl and 1 ml of sample 0.1
ml of solution is plated on R2A plates (Leberechtc, 2010).
Modifications were made to this image.
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Figure 14: HPC Samplers (left) and nutrient agar plates (right) incubating at 30 ℃.

Figure 13: Serial dilutions 10-1 to 10-4 results of STD (top row) and EXP EPGs (bottom row) after
72 hours of incubations.
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Identification of Isolates
Bacterial colonies were initially identified based on their macro physical characteristics
such as colony color, colony morphology, and colony size (Ozdemir and Ceyhan, 2010). The
bacteria identified were catalogued and given a letter designation. Then, the micro physical
characteristics were used to further identify them based on their cell morphology and Gramstaining reaction (Ozdemir and Ceyhan, 2010). After the bacteria were identified they were
catalogued for which samples they were present in. The top 20 bacteria that were most frequently
present in the samples were then consistently isolated so further testing could be performed on
them and further identify attributes of the bacteria.
Microbial Diversity
The diversity of bacteria present in the cooling towers was evaluated by species richness.
Species richness was the number of different bacteria present in a particular sampling population.
The abundance of the species was determined by how frequently an identified bacteria was
present in samples. This value was not the number of colonies of a bacteria present in a sample,
but the number of times is appeared in sampling populations (ex. EPG treatment, season).
Antibiotic Resistance
The bacteria with the top 20 frequency presence were tested for antibiotic resistance
using the Kirby Bauer disc diffusion method (Hudzicki, 2016). Colonies were grown in 10 ml of
TSB broth for 48 to 72 hours at 30 ℃, shaking at 140 rpm. Aseptic technique with a sterile swab
was used to streak the broth culture on a Muller-Hinton agar plate to form a bacterial lawn. The
plate was allowed to dry for about 5 minutes then, antibiotics were dispensed on the agar. The
following antibiotics were used: ceftriaxone, amikacin, levofloxacin, ampicillin, amoxicillin/
clavulanic acid, ticarcillin, doxycycline, sulfamethoxazole/ trimethoprim, ciprofloxacin,
mezlocillin, cefixime, lomefloxacin, carbenicillin, tobramycin, imipenem, cephalothin, oxacillin,
piperacillin, cefepime, sulfadiazine, minocycline, and meropenem. These antibiotics were chosen
since they are currently in clinical use in hospitals (Whitburn, 2019). To ensure attachment of
each antibiotic disc flame-sterilized forceps pressed each antibiotic disc to the agar. The plates
were then incubated for 3 to 4 days at 30 ℃. Next, the zones of inhibition were measured for
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each bacterium’s reaction to the antibiotic. A ruler recorded the diameter of the zones of
inhibition in millimeters (Figure 15). Finally, the zones of inhibition were compared to published
manufacture standards to determine the resistance to antibiotics of these bacteria (Hudzicki,
2016; Becton Dickinson and Company, 2011). Antibiotic zones of inhibition which determined
antimicrobial susceptibility can vary based on specific bacteria (Becton Dickinson and Company,
2011). However, the bacteria identity was not determined prior to this test. Therefore, the
reference zones of inhibition which determined antimicrobial susceptibility were based on the
highest resistance zones of inhibition for each antibiotic, rather than specific bacteria. Antibiotic
zones of inhibition are attached in Appendix A. The structures of these antibiotics are attached in
Appendix B.
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Figure 15: Kirby Bauer disc diffusion method. Bacteria was plated on Muller-Hinton plates with
antibiotic discs. Bacterial resistance was measured by the diameter of the zone of inhibition
around the antibiotic disc.
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Bacterial Identification of the 16S rRNA Gene
A subset of the bacteria found in the water samples were identified using their 16S rRNA
gene. The subset of bacteria was decided because they had a high frequency presence in the
water samples and were more than 60% resistant to the 24 antibiotics. The 16S rRNA gene was
chosen since it was a sufficient sequence length to reflect important sequence changes that
identify bacterial genera. To isolate the bacteria for gene sequencing, pure cultures of the
bacteria were grown on PCA plates for 72 hours and stored at 4℃. Then Polymerase Chain
Reaction (PCR) was performed on the bacteria such that the 16S rRNA gene 3 and 4 variable
regions (V3/V4) were amplified using the primers 314f (5’-CCTACGGGNGGCWGCAG-3’)
and 805r (5’-GACTACHVGGGTATCTAATCC-3’) (Klindworth et al., 2013; Parthasarathy et
al., 2019). The PCR master mix solution used 10.5 µL H2O Rnase Free Sterile Water, 1 µL of
the forward primer, 1 µL of the reverse primer, and 12.5 µL of the GoTaq™ Green (Promega)
per each bacteria sample. Then a small amount of bacteria was added to the solution. Finally, the
whole solution was placed in a thermocycler. The thermocycler PCR conditions were based on
those used in Parthasarathy et al. (2019) edits to these methods were due to lab methods
developed by Dr. Andre Hudson’s lab at RIT. The first cycle was for two minutes at 95 ℃, then
30 cycles for 30 seconds at 95 ℃, 3 minutes at 72 ℃, five minutes at 72 ℃, and the temperature
was held at 4 ℃. Next, gel electrophoresis and gel extraction was used to confirm the V3/V4
amplifications using the QIAquick Gel Extraction Kit (Qiagen) and Sanger nucleotide
sequencing of the 314f and 805r primers (Parthasarathy et al., 2019). The gel for the gel
electrophoresis was made using 0.7 g of Agarose and 100 mL of 1 x TAE. Then, 5 µL of the
DNA samples and the ladder were inserted into the wells and the gel was run for 45 minutes.
Then the gel was placed in a UV light box and the presence of fluorescent bands indicated
successful DNA extraction (Figure 16). Next, the samples were purified using the EZ-10 Spin
Column PCR Products Purification Kit (Bio Basic Inc., 2015) (Figure 17). In an EZ-10 column
20 µL of the PCR product, previously used for the gel electrophoresis, was combined with 150
µL of binding buffer II and centrifuged at 10,000 rpm for 1 minute. Then, the flow through
contents were discarded and 200 µL of wash solution was added to the column and centrifuged
at 10,000 rpm for 2 minutes. The column was transferred into a 1.5 ml microfuge tube and the
flow through was discarded. Twenty-five microliters of the elution buffer was added to the
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column. The column and microfuge tube were spun in a centrifuge together at 10,000 rpm for 1
minute to elute the DNA. A NanoDrop fluorometer was used to find the DNA quantity of the
PCR products. Preparation of the samples to send to Genewiz sequencing required to addition of
1 µL of the forward primer, H2O RNASE free sterile water, and purified PCR product template
DNA to a 1.5 ml microfuge tube. The equations 1 and 2 were used to determine the amount of
purified PCR product template DNA and H2O RNASE free sterile water. Finally, the samples
were sent to Genewiz for sequencing and the Basic Local Alignment Search Tool (BLAST)
identified the bacteria genera based on the sequence (Parthasarathy et al., 2019).
Equation 1: Purified PCR product template DNA
Amount of template DNA = 20 ÷ Nucleic Acid (ng/µL)
Equation 2: H2O RNASE free sterile water
Free sterile water = 15 − Template DNA − Forward Primer
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Figure 17: Electrophoresis gel results under UV light. The ladder was run on the farthest left well and
the samples bands were run in the well to the right of it.

Figure 16: Solutions used for DNA preparation to send to Genewiz from the EZ-10 Spin Column
PCR Products Purification Kit. From left to right: Binding Buffer II, Wash Solution, and Elution
Buffer.
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Statistical Analysis
A statistical analysis was performed using the statistical software R and Minitab. The
cooling tower bacterial loads of CFUs/ml were evaluated statistically for sameness using one
way blocked ANOVAs with incubation time as the blocking variable. The hypothesis for these
tests were:
1) The bacterial CFUs from each building would be the same throughout the sampling
period with the same EPG.
2) Seasonality would not affect bacterial CFUs therefore, CFUs/ml would be statistically
the same throughout the fall and summer sampling periods in 2020.
3) The bacterial CFUs would be statistically different from each EPG treatment.
Tukey’s honesty significant difference test (Tukey’s HSD) followed these tests if there was a
significant difference to determine which sample means were significantly different.
The Gram stain results were statistically evaluated to determine which bacteria Gram
stain identification was most present in the cooling towers. One proportion Z tests and goodness
of fit tests were respectively used to determine Gram stain presence and distribution. Finally, the
EPG comparisons and comparisons between buildings were evaluated using two-sample t-tests.
Chapter 4: Bacteria Enumeration
Results
EPG Comparison of CFUs Results
The results from the EXP and STD EPG from December 2018 to December 2020 showed
the bacteria levels fluctuate throughout the year and did not appear to have a seasonality trend
(Figure 18, 19). Overall the STD EPG was able to keep bacterial levels below 6.6 log CFU/ml
(Figure 18). The bacteria enumerations from the EXP EPG were all below 6 log CFU/ml
indicating the EXP EPG was able to have a lower maximum bacteria CFU threshold as
compared to the STD EPG (Figure 19). The EXP EPG also had a negative linear trend, thus as
the EXP EPG use increased in time, the number of bacteria present in the tower decreased.
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Figure 18: The STD EPG bacteria enumeration results from December 2018 to December 2020 of BLD 2, 14, and 76 after
incubations of 48 hours.
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Figure 19: The EXP EPG bacteria enumeration results from December 2018 to December 2020 of BLD 14 after
incubations of 48 hours.
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Statistical Analysis of Bacteria Enumeration
The EPG devices were evaluated statistically using two sampling periods during 2020.
The preliminary samplings before July of 2020 were excluded from this analysis because the
EXP EPG had changes made to its PEF to improve its ability to lyse bacterial cells. The
sampling period deemed summer sampled from July to September. During this period BLD 14
was treated with the EXP EPG and BLD 76 was treated with the STD EPG. The sampling period
deemed fall was from October to December where both BLD 14 and 76 were treated with the
STD EPG. The 2020 sampling period allowed for a paired comparison of the EPGs and buildings
at the same dates.
Summer Sampling Period Statistical Results
The microbial enumerations of BLD 14 and 76 samples grown on nutrient agar during the
summer sampling period indicated a large amount of variation with a sum of squares of 288.3
(Figure 20, Table 1). The samples taken within the same tower had a large variance. A one way
blocked ANOVA that used incubation time as a blocking variable determined there were
significant differences in the bacteria CFUs of each sample (Table 1). A Tukey’s HSD found that
many of the samples were significantly different from each other and there was not a trend which
indicated if sampling date or building was the cause of these differences (Table 2). Due to the
high frequency of variation between all the samples each tower was evaluated independently to
determine if the variance was due to the EPG treatment or another factor. The independent
analysis of BLD 14 and 76 had a significant p-value indicating the bacteria levels within the
same building’s cooling tower were different from each other (Table 1). Therefore, the bacterial
CFUs throughout this sampling period were not uniform within each tower, which was
unexpected.
The HPC samplers results were also statistically analyzed using the same tests as those
conducted on the nutrient agar counts. These revealed that some of the sampling dates and
buildings tested with the different EPG units were significantly different (Table 1). A Tukey’s
HSD showed the significantly different samples were samples from the same building and EPG
and samples from different building and EPG, suggesting EPG was not influencing CFUs
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significantly (Appendix C). A two-sample t-test also revealed the EPG treatments did not cause a
significant difference in CFUs/ml of bacteria (Table 3).
Fall Sampling Period Statistical Results
During the fall sampling period both cooling towers were treated with the STD EPG.
This was used to compare the bacterial levels within each building’s cooling tower to see if the
conditions of each cooling tower would impact CFUs/ml. The results of one way blocked
ANOVA of all the samples in the fall sampling period from the nutrient agar counts and HPC
test samplers both concluded there were a significant differences in CFU/ml between each
sample (Table 6; Figure 21). The Tukey’s HSD of the nutrient agar and HPC test sampler
enumerations proved there was variance between the samples even though the EPG treatment
was the same throughout the sampling period (Table 7, 9). The nutrient agar Tukey’s HSD
indicated there were significant differences were between BLD 14 and BLD 76 samples, where
five of the 12 comparisons of the buildings were significantly different (Table 7). In comparison,
the HPC test sampler differences were due to variances between the buildings and between the
sampling dates 10/12 and 10/26 (Table 9). A two-sample t-test was run on the HPC test sampler
results to compare the building CFUs which found the CFU levels between the buildings were
distinct, where BLD 76 had higher CFUs than BLD 14 (Table 4, 5). Therefore, the individual
cooling towers had an affinity to have unique bacterial loads even when treated with the same
EPG device. However, a further analysis was performed independently on each buildings to
confirm this.
A one way blocked ANOVA with a blocking variable of incubation time was run on the
nutrient agar CFUs of BLD 76. This test was used to determine if there was a difference in the
microbial CFUs between sampling dates. The tests results found there was not a difference
between the samples, thus indicating the bacteria load within the BLD 76 using the STD EPG
was uniform throughout the sampling period (Table 6). The same test was run on BLD 14, which
resulted in a p-value that was less than the alpha indicating there was a significant difference in
the samples (Table 6). Tukey’s HSD indicated the samples from 12/1 were significantly different
than the other samples taking during this sampling period (Table 8). Suggesting, BLD 14 had a
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homogenous bacterial load expect in 12/1. Therefore, conditions in each cooling tower were
distinct from each other yet homogenous within each tower.
Statistical Comparisons of EPGs Results
In comparing all the samples CFUs in the 2020 sampling period using a two-sample t-test
it was determined the bacterial CFU levels did not differ by their EPG treatment (Table 10). In
addition, a two-sample t-test was performed on the summer period and all the BLD 14 samples.
The summer period was used to compare the different EPGs bacterial growth during the same
time periods. The BLD 14 was used to compare the different EPGs bacterial growth within the
same cooling tower to hold the building variable constant since each buildings environmental
conditions are unique and may be influencing bacterial levels. In evaluating the CFUs from all
the sampling in BLD 14 it was determined that EPGs had an equal effect on the cooling tower
CFUs (Table 10). The same was found for the summer sampling period results which compared
the EXP and STD EPGs (Table 3). Therefore, these devices were unable to show that one EPG
was more effective at reducing the number of bacteria in the towers.
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Figure 20: The bacterial populations of BLD 14 and 76 in the summer sampling period. During this period BLD 14 was
treated by the EXP EPG and BLD 76 was treated by the STD EPG.
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Table 1: One way blocked ANOVA with incubation time was used as the blocking variable for
samples in the summer sampling period (p ≤0.05).
One Way ANOVA Test Samples

Df

All Samples Nutrient Agar CFUs

11

288.3

Bld 14 Samples Nutrient Agar CFUs

5

Bld 76 Samples Nutrient Agar CFUs

5

All Samples HPC Samplers

Sum Sq Mean Sq

F value

P-value

26.21

13.72

<2e-16 ***

157.4

31.482

15.22

2.08e-12 ***

129.53

25.905

14.846

4.2e-12 ***

11 105.703

9.6094

22.86

0.000
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Table 2: Tukey’s HSD in the summer sampling period for all samples of the nutrient agar CFUs.
This table only represents the compared samples that were significantly different from each
other.
Comparison of Samples

P-value

7/6/20 Bld 14-7/21/20 Bld 14

0

7/6/20 Bld 76-7/21/20 Bld 14

0

8/3/20 Bld 14-7/21/20 Bld 14

0

8/3/20 Bld 76-7/21/20 Bld 14

0

7/6/20 Bld 14-7/21/20 Bld 76

0

7/6/20 Bld 76-7/21/20 Bld 76

0

8/3/20 Bld 14-7/21/20 Bld 76

0

8/3/20 Bld 76-7/21/20 Bld 76

0

8/25/20 Bld 14-7/6/20 Bld 14

0

8/25/20 Bld 76-7/6/20 Bld 14

0

9/22/20 Bld 14-7/6/20 Bld 14

0

9/22/20 Bld 76-7/6/20 Bld 14

0

9/8/20 Bld 14-7/6/20 Bld 14

0

9/8/20 Bld 76-7/6/20 Bld 14

0

8/25/20 Bld 14-7/6/20 Bld 76

0

8/25/20 Bld 76-7/6/20 Bld 76

0

9/22/20 Bld 14-7/6/20 Bld 76

0

9/22/20 Bld 76-7/6/20 Bld 76

0

9/8/20 Bld 14-7/6/20 Bld 76

0

8/3/20 Bld 14-8/25/20 Bld 14

0

8/3/20 Bld 76-8/25/20 Bld 14

0

8/3/20 Bld 14-8/25/20 Bld 76

0

8/3/20 Bld 76-8/25/20 Bld 76

0

9/22/20 Bld 14-8/3/20 Bld 14

0

9/22/20 Bld 76-8/3/20 Bld 14

0.03
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Table 2 Continued
Comparison of Samples

P-value

9/22/20 Bld 14-8/3/20 Bld 76

0

9/22/20 Bld 76-8/3/20 Bld 76

0
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Table 3: Two-sample t-test on the HPC Samplers comparing CFU/ml from each EPG treatment
during the summer sampling period (p ≤ 0.05).
Two-sample t-test Results
All Summer Samples HPC Samplers

Df

T- value

P-value

105

0.09

0.930

Table 4: Two-sample t-test on the HPC Samplers comparing CFU/ml from each building in the
fall sampling period (p ≤ 0.05).
Two-sample t-test Results

Df T- value

All Fall Samples HPC Samplers Compared by BLD

60

-3.93

P-value
0.00

Table 5: Descriptive statistics of two-sample t-test on the HPC Samplers comparing CFU/ml
from each building in the fall sampling period (p ≤ 0.05).
Building

N

Mean

StDev

SE Mean

Bld 14

36

475

786

131

Bld 76

27

1141

560

108
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Figure 21: Bacterial log CFUs/ml in BLD 14 and BLD 76 cooling tower while treated by the STD EPG during the fall
sampling period. The box plots represent the bacteria enumerations at each incubation time and sample.

Saxena 56

Table 6: One way blocked ANOVA on nutrient agar CFUs in the fall sampling period with
incubation time as blocking variable.
Sample Populations

Df

Sum Sq

Mean Sq

F value

P-value

6

86.9

14.49

7.25

3.9e-07 ***

Samplers CFUs

6

29.140

4.8566

8.51

0.000***

Fall BLD 76 Nutrient Agar CFUs

2

9.08

4.538

1.682

0.191

Fall BLD 14 Nutrient Agar CFUs

3

43.28

14.425

9.711

0.0000074***

All Fall Sampling Period Nutrient
Agar CFUs
All Fall Sampling Period HPC
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Table 7: Tukey’s HSD of all the fall 2020 samples of the nutrient agar CFUs. *bold values
indicate a significant difference between samples
Comparison of Samples

P-value

10/12/20 Bld 76-10/12/20 Bld 14

0.8915605

10/26/20 Bld 14-10/12/20 Bld 14

0.9820173

10/26/20 Bld 76-10/12/20 Bld 14

0.116753

11/9/20 Bld 14-10/12/20 Bld 14

0.7582261

11/9/20 Bld 76-10/12/20 Bld 14

0.0197647

12/1/20 Bld 14-10/12/20 Bld 14

0.0729359

10/26/20 Bld 14-10/12/20 Bld 76

0.3972033

10/26/20 Bld 76-10/12/20 Bld 76

0.7786506

11/9/20 Bld 14-10/12/20 Bld 76

0.1071202

11/9/20 Bld 76-10/12/20 Bld 76

0.3678941

12/1/20 Bld 14-10/12/20 Bld 76

0.664001

10/26/20 Bld 76-10/26/20 Bld 14

0.0107404

11/9/20 Bld 14-10/26/20 Bld 14

0.9949631

11/9/20 Bld 76-10/26/20 Bld 14

0.0010432

12/1/20 Bld 14-10/26/20 Bld 14

0.0056496

11/9/20 Bld 14-10/26/20 Bld 76

0.0009948

11/9/20 Bld 76-10/26/20 Bld 76

0.995452

12/1/20 Bld 14-10/26/20 Bld 76

0.9999963

11/9/20 Bld 76-11/9/20 Bld 14

0.0000669

12/1/20 Bld 14-11/9/20 Bld 14

0.0004673

12/1/20 Bld 14-11/9/20 Bld 76

0.9993518
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Table 8: Tukey’s HSD of the BLD 14 fall sampling period nutrient agar CFUs. *bold values
indicate a significant difference between samples.
Comparison of Samples
10/26/20 Bld 14-10/12/20 Bld 14

P-value
0.7730186

11/9/20 Bld 14-10/12/20 Bld 14

0.32072

12/1/20 Bld 14-10/12/20 Bld 14

0.0069521

11/9/20 Bld 14-10/26/20 Bld 14

0.8745764

12/1/20 Bld 14-10/26/20 Bld 14

0.0002306

12/1/20 Bld 14-11/9/20 Bld 14

0.0000101
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Table 9: HPC test samplers fall sampling period Tukey’s HSD. *bold values indicate a
significant difference between samples
Difference of Sample Levels

P-Value

10/12/2020 Bld 76 - 10/12/2020 Bld 14

0.582

10/26/2020 Bld 14 - 10/12/2020 Bld 14

0.012

10/26/2020 Bld 76 - 10/12/2020 Bld 14

0.627

11/9/2020 Bld 14 - 10/12/2020 Bld 14

0.996

11/9/2020 Bld 76 - 10/12/2020 Bld 14

0.146

12/1/2020 Bld 14 - 10/12/2020 Bld 14

1.000

10/26/2020 Bld 14 - 10/12/2020 Bld 76

0.000

10/26/2020 Bld 76 - 10/12/2020 Bld 76

1.000

11/9/2020 Bld 14 - 10/12/2020 Bld 76

0.226

11/9/2020 Bld 76 - 10/12/2020 Bld 76

0.979

12/1/2020 Bld 14 - 10/12/2020 Bld 76

0.690

10/26/2020 Bld 76 - 10/26/2020 Bld 14

0.000

11/9/2020 Bld 14 - 10/26/2020 Bld 14

0.062

11/9/2020 Bld 76 - 10/26/2020 Bld 14

0.000

12/1/2020 Bld 14 - 10/26/2020 Bld 14

0.007

11/9/2020 Bld 14 - 10/26/2020 Bld 76

0.257

11/9/2020 Bld 76 - 10/26/2020 Bld 76

0.969

12/1/2020 Bld 14 - 10/26/2020 Bld 76

0.732

11/9/2020 Bld 76 - 11/9/2020 Bld 14

0.033

12/1/2020 Bld 14 - 11/9/2020 Bld 14

0.985

12/1/2020 Bld 14 - 11/9/2020 Bld 76

0.206
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Table 10: Two-sample t-test of building comparisons from the all samples in the 2020 sampling
period.
Comparison of EPGs

T-Value

DF

P-value

Nutrient Agar CFUs at 24 hr

-0.67

40

0.507

Nutrient Agar CFUs at 48 hr

0.41

30

0.686

Nutrient Agar CFUs at 72 hr

0.54

27

0.592

Samples from BLD 14 at 48 hr

0.49

5

0.643

HPC Samplers CFUs at 48 hr

0.09

30

0.930

All 2020 Nutrient Agar CFUs

Discussion
EPG Comparison
The acceptable levels for heterotrophic bacteria in cooling towers are 5 log CFUs
(Monash University, 2017). The EXP and STD EPGs both surpassed this level at one point or
another but it was relatively infrequent and the bacteria load was quickly reduced below this
level (Figure 18, 19). About 20% of the samples from the EXP EPG were above 5 log CFUs.
However, the sampling period following the high bacterial load usually had CFUs that were
reduced below this limit (Figure 19). In contrast the STD EPG had a higher CFU limit, 6.6 log
CFUs but, this only occurred twice in the 30 STD EPG samples. This occurrence was during the
preliminary data collection in BLD 2 where sampling was later discontinued due to the loss of
sanitation contract. Excluding the two abnormally high CFUs in BLD 2, the STD EPG maximum
CFUs was 4.7 log, therefore all of the STD EPG CFUs were below the allowable limit.
The cause of the excessive bacterial growth in either EPG was unclear, though it did not
appear to be associated with seasonality. There were not trends that suggested seasonality
affected bacterial CFUs because the same month could have very different CFUs (Figure 18, 19).
Additionally, the same sampling date could have profoundly different CFUs in different cooling
towers. The relative abundance of bacteria changed over time, however each cooling tower did
not follow the same trend indicating that unique environmental conditions in each building were
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responsible for these changes (Tsao et al., 2019). Therefore in comparison, the STD EPG was
able to reduce the bacterial load below the allowable levels more frequently than the EXP.
Statistical Analysis of Microbial Enumeration
The bacterial community in the summer sampling period determined there was a
difference in means among the different samples tested by the EXP EPG in BLD 14 and the STD
EPG in BLD 76. However, this did not prove the CFUs difference was due to the EPG device.
Tukey’s HSD revealed a majority of the variation in this comparison was due to CFU variation
within the same building. This indicated there was not uniformity within each building’s cooling
tower, thus a factor other than the EPGs was influencing bacterial growth. Factors such as wind,
weather, and seasonal climates may be affecting the bacterial community in the cooling towers
causing the CFUs to be higher or lower at the time of sampling (Tsao et al., 2019). Additionally,
these towers were monitored by RIT facilities, if bacterial levels got too high the EPGs may be
overridden by a chlorine treatment to kill the excess of bacteria. This may have occurred on
7/6/20 when bacteria CFUs were at 0. In conclusion, the statistical results were inconclusive as
to why the summer period had so much variation, especially within their own towers.
The fall sampling period followed the same trend of variance as the summer sampling
period. Even though all samples were treated by the STD EPG device during this period the
bacterial loads were not statistically the same. This further confirmed that each cooling tower has
a unique environment (Tsao et al., 2019). BLD 76 being an outdoor tower had different
environmental conditions that may have influenced the bacterial community differently than
BLD 14 which was an indoor cooling tower. When each building was evaluated independently,
the samples within BLD 76 had similar bacterial loads, this differed from the summer sampling
period. BLD 14 during the fall sampling period also had homogeneous CFUs except for its 12/1
sample, however this variance could have been caused by start of winter. This suggested the
summer months caused bacteria loads to vary more significantly than fall months. Therefore,
there may have been a seasonal effect where warmer months cause more variation in CFUs, than
cooler months.
Overall the STD EPG and the EXP EPG showed they controlled bacterial growth the
same. When compared to each other there was no significant difference between the treatments.
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However, the enumerations alone showed that the STD EPG was able to more frequently keep
bacterial CFUs below allowable levels. Therefore, the STD EPG may be able to reduce CFUs
better than the EXP EPG, however this was not proved statistically.
Chapter 5: Bacterial Community
Results
Species Presence Results
The bacteria that appeared in the cooling tower samples varied vastly. Species presence
was determined by counting the number of times a bacteria, as identified by Appendix D,
appeared in a sample. The frequency presence within the bacteria community of all the samples
determined that only 18 of the 77 bacteria appeared in a sample more than 5 times (Figure 22).
The top five bacteria that appeared most frequently in all the samples were present in all seasons,
EPG treatments, and cooling tower buildings. In comparison of the EPG treatments 34 of the
same bacteria was present in both the STD EPG (54% of the population) and EXP EPG
treatments (71% of the population) (Figure 23, 24). Only 24 bacteria were present throughout
both the summer and fall sampling seasons. The summer sampling period had 60% unique
bacteria in their population, while the fall sampling period had 41% unique bacteria in their
population (Figure 25, 26). Consequently, the STD EPG and summer sampling period had a
higher abundance of unique bacteria.
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Figure 22: Frequency bacteria appeared in all samples. This graph only represents the bacteria
with a frequency greater than five.

29%

71%

% common bacteria
% unique bacteria

Figure 23: The common bacteria between the EPG treatments as a percent of the EXP EPG
bacterial population in the summer sampling period.
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46%
54%

% common bacteria
% unique bacteria

Figure 24: The common bacteria between the EPG treatments as a percent of the STD EPG
bacterial population in the summer sampling period.

40%

60%

% common bacteria
% unique bacteria

Figure 25: The common bacteria between seasons as a percent of the summer sampling period
bacterial population.
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41%
59%

% common bacteria
% unique bacteria

Figure 26: The common bacteria between seasons as a percent of the fall sampling period
bacterial population.
Species Richness Results
The bacterial species richness of the samples was collected to determine the diversity of
the bacterial communities within the cooling towers. The species richness was a count of the
different bacteria that appeared in the samples. The overall richness of all the samples was 77
species. In comparison of the EPGs the STD EPG had a higher species richness than the EXP
EPG (Table 11). The summer sampling period which compared the EPG devices on the same
dates found the EXP EPG had a species richness of 48, while the STD EPG had a species
richness of 42 in the summer sampling period. Therefore, the samples taken at the same time
from the different EPGs showed a similar diversity. However in observing all the 2020 samples,
the EXP EPG had a lower species richness (Table 11). This could be due to the fact that there
was more data on the STD EPG inflating its diversity. The STD EPG overall in the fall sampling
period had lower diversity than the summer. Therefore, the comparison in the summer period
was more accurate to compare the EPG treatments.
In observing each building individually, BLD 76, which was only treated by the STD
EPG, had a species richness of 55, while BLD 14 which was treated by both the EXP and STD
EPG had a species richness of 59 (Table 11). Therefore, the bacteria diversity between these
buildings did not vary vastly. Seasonality from summer to fall revealed the diversity reduced
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significantly in the fall sampling period. The diversity in BLD 14 in the summer sampling period
had a species richness was 48, however the fall sampling period showed a drop in diversity to 28.
BLD 76 had a decline in species richness from 42 to 9 from the summer to fall sampling period.
Seasonality proved the summer sampling period had a higher species diversity than the fall
(Table 11).
Table 11: Bacterial species richness present in different sampling populations.
Sample Population

Species Richness

Bacteria Presence of All Samples (all BLDs, EXP & STD EPG)

77

STD EPG Richness

63

EXP EPG Richness

48

Summer Sampling Species Richness (Both EXP & STD EPG)

60

Fall Sampling Species Richness (STD EPG)

41

BLD 76 Richness All Samples (STD EPG)

55

Summer Sampling Richness of the STD EPG in BLD 76

42

Fall Sampling Richness of the STD EPG in BLD 76

9

BLD 14 Richness All Sampling (Both EXP & STD EPG)

59

Summer Sampling Richness of the EXP EPG in BLD 14

48

Fall Sampling Richness of the STD EPG in BLD 14

28

Gram Stain Results
From the cooling tower water samples, 77 distinct bacteria were identified. Of those 77
identified 72 were able to be successfully Gram stained, the inability to Gram stain was due to
issues isolating particular bacteria. All Gram stains are described in Appendix E. The Gram
stained bacteria had was a higher frequency (55%) of Gram negative bacteria (43), than Gram
positive bacteria (29) (Table 12), although this was not a statistically significant majority (Table
13). Of the different treatments Gram negative bacteria held the statistical majority in the STD
EPG treatment samples, while there was an even distribution of Gram negative and positive
bacteria in the EXP EPG treatment samples (Table 13). Those that were Gram negative were
mostly bacillus (30) rather than coccus (13). The Gram positive bacteria had an even distribution
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of bacillus (15) and coccus (14) (Table 12). A goodness of fit test was run on the Gram stain and
shape results to determine which Gram stain result was most present in the samples. This proved
the distribution of the Gram stain results was not equal (p-value 0.013). The Gram negative
bacilli had the highest presence and the most influence in disrupting the equal distribution of the
bacteria Gram stain results since the observed frequency was much higher than the expected
frequency of Gram negative bacilli (Table 14). These results showed that Gram negative bacilli
were the dominant bacteria present in cooling towers and the EXP EPG was able to reduce Gram
negative populations more effectively than the STD EPG.
Table 12: Summary of Gram stain results.
Gram Stain Results

Frequency

Gram Negative

43

Bacillus

30

Coccus

13

Gram Positive

29

Bacillus

15

Coccus

14

unable to isolate for gram stain

5

Table 13: 1 Proportion Z test on the Gram stains from the bacteria documented in the samples.
These tests were performed such that Gram negative was ≠ 0.5 to determine if Gram negative
bacteria were the majority of the bacteria in the tower.
Samples

N Event

95% Confidence Interval

Z-Value

P-Value

All Bacteria Gram Stains

72

43

0.4818067, 0.7027889

1.65

0.09896

STD EPG Bacteria Gram Stains

61

38

0.517716, 1.000000

3.6885

0.02739

EXP EPG Bacteria Gram Stains

43

23

0.3891564, 0.6748894

0.2093

0.6473

Saxena 68

Table 14: Chi square goodness of fit Gram stain result contributions.
Category

Observed

Test Proportion

Expected Contribution to Chi Square

negative bacillus

30

0.25

18

8.00000

negative coccus

13

0.25

18

1.38889

positive bacillus

15

0.25

18

0.50000

positive coccus

14

0.25

18

0.88889

Antibiotic Resistance Results
A subset of the bacteria that were frequently present in the cooling towers was tested for
antibiotic resistance. These bacteria had the top 20 highest presence in the towers, meaning they
appeared in the cooling tower samples more than four times with one appearing only three times.
Half of the tested samples were resistant to 50% or more of the 24 antibiotics tested (Figure 27).
Of the bacteria present in each EPG treatment which were tested for antibiotic resistance, 60% of
the bacteria in the EXP EPG treatment and 50% of the bacteria in the STD EPG treatment were
resistant to at least half of the antibiotics (Table 15, 16). The STD EPG contained more bacteria
that were antibiotic resistant than the EXP EPG. Of the antibiotics tested, ampicillin and
oxacillin were obsolete, all of the bacteria tested were 100% resistant to them. Imipenem,
doxycycline, minocycline, and levofloxacin were most effective (85-95%) against the cooling
tower bacteria, with 15% or less of resistance to these antibiotics (Figure 28).
The bacteria present in the cooling towers did not always have a uniform bacterial
population. In some cases the bacterial community contained multiple populations that had
different antibiotic sensitivities even though they were grown as a pure culture. Of the bacteria
tested, 62% of them contained multiple populations that were resistant and sensitive to one or
more antibiotic (Figure 29). In these cases the bacteria zones of inhibition were based on their
most resistant antibiotic sensitivity.
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Figure 27: Cooling tower bacteria antibiotic resistance.
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Figure 28: Percent of cooling tower bacteria which were resistant to an antibiotic.
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Table 15: EXP EPG antibiotic resistance and bacteria frequency.
Bacteria Designation

Frequency in samples

% Antibiotic Resistance

RY

6

88%

YL

5

85%

DY

4

79%

BBW

4

77%

CW

6

77%

BY

10

69%

F

2

60%

UK

3

60%

FY

5

58%

T

10

54%

BC

4

50%

UY

3

50%

BW

7

46%

DLY

2

40%

RW

8

40%

WC

7

29%

B

3

27%

O

3

25%

PY

3

19%

Y

11

19%
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Table 16: STD EPG antibiotic resistance and bacteria frequency.
Bacteria Designation

Frequency in samples

% Antibiotic Resistance

RY

1

88%

BBW

1

77%

CW

3

77%

BY

3

69%

F

2

60%

UK

1

60%

T

5

54%

UY

2

50%

BW

3

46%

DLY

1

40%

RW

2

40%

WC

1

29%

B

3

27%

O

1

25%

PY

1

19%

Y

4

19%
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Figure 29: Image of antibiotic sensitivity test on BC bacteria showing multiple populations with
different antibiotic sensitivities. The antibiotic under the BC label and going clockwise the 4 th
antibiotic also has 2 populations of bacteria with different resistances to the antibiotics.
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16S rRNA Gene Bacterial Identification
The results of the 16S rRNA sequencing from Genewiz found the genera of each bacteria and
in most cases the species or likely species. Therefore the species that were present in the cooling
towers were Morganella morganii, Chryseobacterium ureilyticum, Phenylobacterium sp.,
Chryseobacterium cucumeris, Stenotrophomonas maltophilia, Bacillus licheniformis, and
Bacillus cereus (Table 17). The Gram stains and images of these bacterial colonies are presented
in Appendix F. The bacteria identified through the 16S rRNA gene had some discrepancies on
the Gram stain results as compared to the reported Gram stain for the identified bacteria (Table
17). These bacteria were the most common bacteria and all were resistant to more than 46% of
antibiotics tested on them (Table 17, 18).
Table 17: Bacteria that was identified by the 16S rRNA gene attributes.
Bacteria
Designation Bacteria Genera/ Species
BW

Morganella morganii

Documented

Antibiotic

EXP Gram stain

Gram Stain

Resistance

positive coccus

negative bacillus

46%

Chryseobacterium
BY

ureilyticum

negative bacillus

negative bacillus

69%

CW

Phenylobacterium sp.

positive coccus

negative bacillus

77%

negative bacillus

negative bacillus

79%

Chryseobacterium
DY

cucumeris
Stenotrophomonas

RY

maltophilia

negative bacillus

negative bacillus

88%

T

Bacillus licheniformis

negative bacillus

positive bacillus

54%

UK

Bacillus cereus

positive bacillus

positive bacillus

60%
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Table 18: Antibiotic resistance of the bacteria that had their 16S rRNA gene sequenced. R
indicates resistant, S susceptible, and I intermediate antibiotic sensitivity.
Bacteria Designation
Antibiotic

BW

BY

CW

DY

RY

T

UK

Ampicillin

R

R

R

R

R

R

R

Amikacin

S

R

S

R

R

S

S

R

R

R

R

R

R

R

Carbenicillin

S

R

R

R

R

R

R

Cefazolin

R

R

R

R

R

I

R

Cefepime

S

S

R

R

R

R

R

Cefixime

S

R

R

R

R

R

R

Cefoxitin

R

R

R

R

R

S

R

Ceftriaxone

S

R

R

R

R

R

R

Cephalothin

R

R

R

R

R

R

R

Ciprofloxacin

I

I

R

R

R

I

I

Doxycycline

R

S

S

S

S

S

S

Imipenem

S

S

R

S

R

S

S

Levofloxacin

S

S

R

S

S

S

S

Lomefloxacin

R

I

I

R

R

R

I

Meropenem

S

R

R

R

R

S

S

Mezlocillin

I

R

R

R

R

R

I

Minocycline

S

S

S

S

S

S

S

Oxacillin

R

R

R

R

R

R

R

Piperacillin

R

R

R

R

R

R

R

Sulfadiazine

R

I

S

R

R

S

S

S

S

S

S

R

S

R

Ticracillin

S

R

R

R

R

R

R

Tobramycin

S

R

R

R

R

S

S

Amoxicillin/
Clavulanic acid

Sulfamethoxazole/
Trimethoprim
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Discussion
EPG Diversity
In comparing all the samples taken in the 2020 sampling period the STD EPG had a
higher species richness than the EXP EPG (Table 1). This could indicate the EXP EPG was able
to reduce bacteria diversity more effectively than the STD EPG. However, there were more
samples treated with the STD EPG than the EXP EPG which may have skewed the data.
Therefore, the population of the summer sampling period was examined to compare diversity of
each EPG treatment on the same sampling dates. This revealed that the EXP and STD EPG had
very similar species richness. The increase of data for the STD EPG and the significant decline
in diversity in the fall sampling period was likely why the comparison of all samples made the
EXP EPG appear as though it reduced bacterial diversity more effectively than the STD EPG.
The summer sampling period was a more robust analysis of diversity when comparing the EPGs,
thus the EPGs have very little difference in their ability to reduce bacterial diversity and
CFUs/ml.
Species Presence and Richness
Microbial diversity within cooling towers has been a neglected area of study. Few studies
have evaluated bacteria within cooling towers beyond those in association with L. pneumophila
presence (Tsao et al., 2019). This evaluation of diversity determined the species richness and
frequency presence of bacteria within cooling towers in order to evaluate the EPG devices ability
to reduce species diversity. Of the 77 species that were present in all the cooling towers only
23% of them appeared in the samples more than 5 times, thus species presence was variable.
However, the top five bacteria that had the highest frequency presence were not affected by
seasons, specific cooling tower building conditions, or the EPG treatment. Therefore, there were
some bacteria that were constant no matter the conditions.
The majority of bacteria were consistent between the EPG treatments. The between the
EXP and STD EPG there were 34 bacteria that appeared in both of the treatments. Based on the
species richness of the EXP EPG, these 34 bacteria accounted for 71% of the population, while
in the STD EPG they accounted for 54% of the population (Figure 23, 24). This suggests the
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STD EPG fostered a more diverse bacterial community, while the EXP EPG had a simpler
community. This was in agreement with the species richness results where the STD EPG had a
higher species richness than the EXP EPG.
The reduction in diversity could be the result of seasonality. Twenty-four bacteria were
present throughout both the summer and fall sampling seasons. Those 24 consistent bacteria
accounted for 40% of the population in the summer sampling period, while in the fall sampling
period it accounted for 59% of the bacterial population (Figure 25, 26). Therefore, there were
more unique species in the summer than the fall, suggesting there was a trend in seasonality
since there was more diversity in the summer than the fall.
Species richness also showed this seasonality trend. Species richness significantly
decreased from the summer to fall sampling periods. The species richness in BLD 76 declined
from 42 to 9 species, whereas the species richness in BLD 14 decreased from 48 to 28 species. In
BLD 14 the EPG treatment also changed between the summer and fall sampling periods, yet this
diversity decline was more likely from seasonality than EPG treatment since the same diversity
decrease also occurred in BLD 76 where the EPG device was the same throughout the 2020
sampling period. Additionally, the EPG comparison in the summer sampling period found the
EPG treatments resulted in similar diversities, thus the reduced diversity could not be due to EPG
treatment but rather seasonality. The decrease in diversity could be due to the cooler weather
conditions providing injurious conditions for some species (Tsao et al., 2019). The steeper
decrease in the diversity in BLD 76 could be caused by its outdoor connection causing colder
temperatures than within BLD 14 which is an indoor cooling tower. Therefore, seasonality had
an effect on diversity. However, seasonality did not affect CFUs indicating that when some
species were removed other species were able to thrive and grow to similar levels in their place.
Lower diversities may be beneficial for sanitation since it results in fewer bacteria to be
concerned about, yet they are in higher concentrations thus have a higher contamination potential
if pathogenic.
Gram stain
Gram negative bacteria dominate cooling tower bacterial communities (Türetgen, 2004).
Gram negative bacteria are the predominate bacteria in cooling tower biofilms and tend to be
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opportunistic pathogens to immunocompromised humans (Center for Disease Control, 2015).
The high frequency of Gram negative bacilli was concerning since cooling towers can
contaminate large areas both indoors and outdoors and cause infections (Sala Ferré et al., 2009).
The reduction of Gram negative bacteria in the EXP EPG as compared to the STD EPG indicated
the EXP EPG can reduce the number of potentially pathogenic bacteria more effectively than the
STD EPG. However, the bacteria tested in this study for antibiotic resistance had a relatively
equal distribution of Gram negative and positive bacteria, which were both particularly resistant
to the antibiotics tested (>60%) (Figure 15). As a result, although Gram negative bacteria is
known to likely be pathogenic, in this study it did not indicate a higher affinity to antibiotic
resistance.
Antibiotic Resistance
Although it is known that cooling towers are hotspots for biofilms where genetic
exchange can occur, there are few studies that evaluate the antibiotic resistance within cooling
towers (Fux et al., 2005; Hausner and Wuertz, 1999; Li et al., 2002; Molin and Tolker-Nielsen,
2003; Ozdemir and Ceyhan, 2010). This study found that cooling towers had a high presence of
antibiotic resistant bacteria. The antibiotics recommended for cooling tower usage are imipenem,
doxycycline, minocycline, and levofloxacin since they had the highest efficiency (85-95%)
against the cooling tower bacteria (Figure 16). Comparatively, it is not recommended to use
ampicillin or oxacillin since cooling tower bacteria are likely to be resistant to them. These
results were of concern because these antibiotics are widely used in clinical settings (Whitburn,
2019).
The presence of multiple populations of the same bacteria with different susceptibilities
to antibiotics suggests bacteria are actively gaining antibiotic resistance. Sixty-two percent of the
bacteria tested had multiple populations that were resistant and sensitive to one or more
antibiotic, thus there is a significant amount of genetic exchange occurring in cooling towers
(Figure 17). Genetic exchange in cooling towers would result in even fewer antibiotics able to
suppress bacteria. Outbreaks from cooling towers frequently occur in hospitals, thus these
resistance levels and evidence of genetic exchange reduce the antibiotics healthcare providers are
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able to use to treat bacterial infections resulting from cooling tower contamination (Dondero et
al., 1980; Engelhart et al., 2008; García-fulgueiras et al., 2003).
The presence of antibiotic resistant bacteria did not suggest that one of the EPG
treatments was more effective to remove antibiotic resistant bacteria. However, the frequency
antibiotic resistant bacteria appeared in samples was lower in the STD EPG than the EXP EPG
(Table 15, 16). Therefore, although the STD EPG may allow the presence of antibiotic resistant
bacteria their abundance will be lower.
16S rRNA
Bacteria that had a high frequency presence in the cooling towers had their 16S rRNA
gene sequenced to identify the bacteria and determine what implications it could have on the
environment if released from the tower. There were discrepancies in the Gram stain results of the
bacteria isolated from the cooling towers as compared to the reported Gram stains from the 16S
rRNA identified bacteria (Table 17). The experimental Gram stains could have been erroneous
due to over or under use of decolorizer resulting in a false Gram stain. In addition the variance in
bacteria shape could simply have been a misidentification.
The species that were present in the cooling towers were Morganella morganii,
Chryseobacterium ureilyticum, Phenylobacterium sp., Chryseobacterium cucumeris,
Stenotrophomonas maltophilia, Bacillus licheniformis, and Bacillus cereus (Table 17). BW was
determined to be M. morganii, however there was a discrepancy between the experimental Gram
stain as Gram positive coccus, while the documented Gram stain is a Gram negative bacilli
(Falagas et al., 2006). This error could be an excess of crystal violet or not enough decolorizer.
In the cases of BY and CW, the bacilli may have been mistaken for coccus due to their small
size.
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Table 19: Summary of the contamination potential of the identified bacteria.
Bacteria
Morganella morganii

Contamination Potential


Opportunistic pathogen



Broad resistance to antibiotics



Can easily transfer genetic material
between bacteria. The isolate from this
sample has additional antibiotic
resistance than literature reports.



Not likely to cause infection through
aerosol

Chryseobacterium ureilyticum



Resistant to beta-lactams and
carbapenems

Chryseobacterium cucumeris



Opportunistic pathogens



Resistant to beta-lactams and
carbapenems

Phenylobacterium sp.



Opportunistic pathogens



Antibiotic resistance to ampicillin and
carbenicillin

Stenotrophomonas maltophilia



No known pathogenic properties



Resistant to a broad spectrum of
antibiotics



This isolate had 88% antibiotic
resistance



Can cause respiratory issues



Unlikely to survive in dry conditions
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Table 19 Continued
Bacteria
Bacillus licheniformis

Contamination Potential


Isolate with the highest frequency
presence



Non-pathogenic



Forms spores



This isolate was sensitive to
antibiotics it had known resistance to

Bacillus cereus



Unlikely to transfer genes horizontally



Spore forming



Associated with food poisoning,
respiratory tract infections, and
nosocomial infections



Produce β-lactamases and
carbapenemsases



NCCLS recommended the avoidance
of cephalosporin for B. cereus
treatment



Collected bacteria was susceptible to
carbapenems

M. morganii is considered an opportunistic species that persists in the intestines of
animals (Mbelle et al., 2020). It is known to cause urinary tract infections (UTI), meningitis, and
septic arthritis (Falagas et al., 2006; Katz et al., 1987; Mbelle et al., 2020; Samonis et al., 2001).
It also has resistance to a variety of antibiotics and multiple drug resistance (Rojas et al., 2006).
In addition, M. morganii has the ability to easily transfer gene resistance between bacteria of the
same or different species (Hsieh et al., 2015; Liu et al., 2016; Mbelle et al., 2020; Rojas et al.,
2006). Literature has reported M. morganii to be resistant to oxacillin, ampicillin, amoxicillin,
first and second cephalosporins, macrolides, lincosamides, glycopeptides, fosfomycin, fusidic
acid, and colistin (Stock and Wiedemann, 1998).
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This study agrees with these reports as M. morganii was resistant to ampicillin,
amoxicillin/ clavulanic acid, and oxacillin, and cephalosporins: cephalothin, cefazolin, cefoxitin.
In addition, M. morganii was resistant to doxycycline, piperacillin, lomefloxacin, and
sulfadiazine (Table 18). Stock and Wiedemann (1998) also found M. morganii was susceptible to
aztreonam, aminoglycosides, antipseudomonal penicillins, third-and fourth-generation
cephalosporins, carbapenems, quinolones, trimethoprim/ sulfamethoxazole, and
chloramphenicol. The results from this study are in line with these findings except this M.
morganii was resistant to piperacillin and antipseudomonal penicillins, suggesting that while in
the cooling tower M. morganii received genetic resistance genes.
The antibiotic resistance, susceptibility to obtain new antibiotic resistance genes, and
high abundance of M. morganii raised concerns for M. morganii’s presence in cooling towers. M.
morganii is commonly known to cause UTIs in humans which is not communicated through
breathing in an aerosol, however it has a high pathogenic potential in immunocompromised hosts
(Samonis et al., 2001). Therefore, M. morganii in cooling towers are unlikely to pose a risk to
human health directly, however their potential to gain and transfer antibiotic resistance to other
pathogens raises a public health concern.
The bacteria designated BY and DY were identified as Chryseobacterium ureilyticum
and Chryseobacterium cucumeris. Chryseobacterium is a quickly growing genera that is
characterized by its yellow pigmented, Gram negative bacillus bacteria, and lack of motility.
Generally, Chryseobacterium are resistant to beta-lactams and carbapenems (Kim et al., 2020).
This study’s results found DY, Chryseobacterium cucumeris, was resistant to 19 of the 24
antibiotics and BY, Chryseobacterium ureilyticum, was resistant to 15 of the 24 antibiotics. Most
of the resistance of these bacteria was from antibiotics in the beta-lactams and carbapenems
classes. The bacteria in this genera are found in diverse habitats such as freshwater, soil, or dairy
products. These species have also been identified as pathogens in untreated drinking water and
some are opportunistic pathogens to animals (Dworkin et al., 2006). Therefore the high
frequency in cooling towers, documented resistance to antibiotics, and pathogenic potential of
Chryseobacterium sp. identifies a pathogen of concern that could cause disease outbreaks
originating from cooling towers.
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The bacteria designated CW was identified as Phenylobacterium sp. which is a small
novel genera that can inhabit soil or aquatic habitats (Tiago et al., 2005). They are a Gram
negative rod bacteria known to degrade herbicide, specifically chloridazon (Lingens et al., 1985).
This bacterium also had similar antibiotic resistance to literature reports with resistance to
ampicillin and carbenicillin (Aslam et al., 2005). However, being such a novel genera
Phenylobacterium currently does not have any known pathogenic properties. The presence of a
bacteria with antibiotic resistance genes but is not pathogenic is still of concern because it has the
potential to pass that information on to another bacteria that may be pathogenic. This is
especially concerning for cooling towers since they are hot spots for genetic exchange due to
their environmental conditions (Fux et al., 2005; Hausner and Wuertz, 1999; Li et al., 2002;
Molin and Tolker-Nielsen, 2003).
Stenotrophomonas maltophilia was determined to be the identity of RY. This bacteria
was a motile Gram negative bacillus with colonies that were smooth with a glistening yellowwhite color and entire margins (Denton and Kerr, 1998). They have been documented to grow in
a number of aquatic habitats. Infections of S. maltophilia can cause respiratory issues and can be
transmitted through fecal carriage on hands (Denton and Kerr, 1998). S. maltophilia is known to
be resistant to a broad spectrum of antibiotics. There is conflicting data of S. maltophilia
sensitivity to the carbapenem class. Denton and Kerr (1998) state S. maltophilia had particular
resistance to carbapenems while Cullmann and Dick (1990) stated that S. maltophilia only
occasionally had resistance to carbapenems. The strain found in this study showed susceptibility
to the antibiotics in the carbapenem class and disagreed with Denton and Kerr (1998). However,
this study did prove that S. maltophilia is resistant to a broad spectrum of antibiotics with
resistance to 88% of the antibiotics tested, the highest antibiotic resistance of all the bacteria
tested. Therefore, the presence of this bacteria posed serious concern for public health because S.
maltophilia is frequently present in cooling towers, highly resistant to antibiotics, and causes
respiratory illnesses. However, S. maltophilia are unlikely to survive in dry conditions, thus if
aerosolized from a contaminated cooling tower S. maltophilia may die before causing infection
(Hirai, 1991; Moffet et al., 1967; Rosenthal, 1974).
Bacillus licheniformis was the identity of T, a Gram positive bacillus species that forms
spores and occurs naturally in soil and had the highest presence frequently in all the cooling
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tower samples (Duc et al., 2003). It is considered non-pathogenic to humans and is often used in
commercial settings for animal feeds (Cutting, 2011; de Boer et al., 1994). Its ability to form
spores could allow it to evade sanitation events and persist in cooling towers (Bottone, 2010). B.
licheniformis has resistance genes against erythromycin, chloramphenicol, streptomycin, but
these genes are unlikely to be transferred horizontally (Agersø et al., 2019). B. licheniformis also
has carbapenemases which make it resistant to carbapenems, which have the widest activity
spectrum of the β-lactam group (Carfi et al., 1995; Halat and Moubareck, 2020; Queenan and
Bush, 2007).
B. licheniformis was resistant to 54% of the antibiotics in this study many of which were
β-lactams, yet it was sensitive to the carbapenems of this group suggesting this strain did not
contain genes for carbapenemases. Therefore, even though B. licheniformis had the highest
bacteria presence and a 54% antibiotic resistance B. licheniformis does not pose a serious threat
to cooling towers since this species is unlikely to transfer its resistance genes and is not
considered pathogenic to humans (Agersø et al., 2019; de Boer et al., 1994).
Finally, UK was determined to be Bacillus cereus, a spore forming Gram negative
bacillus. As a spore B. cereus can be inactive and essentially protected from an adverse
environment (Bottone, 2010). In a cooling tower environment a spore of B. cereus could be
protected during sanitation events and persist in the tower afterwards. It can inhabit different
aquatic environments, decaying organic matter, and invertebrate intestinal tracts (Berkeley et al.,
1984; Bottone, 2010). B. cereus is associated with food poisoning, respiratory tract infections,
and nosocomial infections where HVAC systems could be bacterial reservoirs (Bottone, 2010;
Bryce et al., 1993). B. cereus produce β-lactamases which renders them resistant to penicillins
and cephalosporins (Bottone, 2010). They also produce carbapenemsases resulting in resistance
to carbapenems (Carfi et al., 1995; Halat and Moubareck, 2020). It also has reported resistances
to penicillin, ampicillin, cephalosporins, trimethoprim, erythromycin, oxacillin, and tetracycline
(Bottone, 2010; Kiyomizu et al., 2008; National Committee for Clinical Laboratory Standards,
1984; National Committee for Clinical Laboratory Standards, 1985; Savini et al., 2009; Turnbull
et al., 2004). B. cereus is so resistant to broad-spectrum cephalosporins that the National
Committee for Clinical Laboratory Standards recommended that cephalosporin treatment use
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should be avoided for suspected B. cereus infections (National Committee for Clinical
Laboratory Standards, 1984; National Committee for Clinical Laboratory Standards, 1985).
These reports of antibiotic sensitivity were consistent with the antibiotic resistance of B.
cereus in this study however, this strain was susceptible to carbapenems suggesting it did not
contain resistance genes for carbapenems. This was interesting, since B. cereus has been
described with carbapenemases (Carfi et al., 1995; Halat and Moubareck, 2020). The association
with respiratory illnesses provides the potential for B. cereus to infect a wide range of people if
released from cooling towers. The substantial amount of known antibiotic resistance of B. cereus
makes infections of B. cereus difficult to treat. Finally, the ability to evade sanitation as a spore
makes B. cereus a pathogen of concern in cooling towers since its release would pose a
significant health risk.
Chapter 6: EPG Evaluation Conclusion and Recommendations for Future Research
In conclusion, the EPG devices were able to reduce bacterial CFUs to levels that are
considered safe for cooling towers. Statistically one device did not perform better than the other
in its ability to reduce the CFUs of bacteria present in the towers. However, the STD EPG was
able to reduce CFUs slightly better than the EXP EPG. The bacterial diversity and antibiotic
resistance between the two EPGs was also consistent. However, the STD EPG had a slightly
lower species diversity and antibiotic resistance indicating it removed more diverse bacteria from
the water. The STD EPG was able to reduce the presence of antibiotic resistant bacteria more
effectively than the EXP EPG. The EXP EPG was able to more efficiently reduce Gram negative
bacteria than the STD EPG. However, Gram stain did not indicate antibiotic resistance since
there was an equal distribution of Gram positive and negative bacteria. The results of this study
found that the STD EPG was able to reduce CFUs/ml and species diversity slightly more
effectively than the EXP EPG. Therefore, the STD EPG was the superior EPG since it had an
overall lower CFUs/ml, diversity, and abundance of antibiotic resistant bacteria. The bacteria this
EPG allowed to persist had a lower potential to cause harm and were unlikely to produce
biofilms as a result of the lower CFUs and cause fewer issues within the cooling tower.
Based on these results there is heightened concern about the bacteria present in these
towers and their potential to contaminate the environments where cooling tower exhausts are
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deposited. The bacteria in the cooling towers was very diverse and it was unclear what factors
influenced their growth. Each cooling tower had unique environmental factors that were likely
affecting the bacterial growth. Seasonality significantly affected species diversity, while CFUs
were constant. However, seasonality did affect the variation within bacteria loads, with more
variation in summer than fall. Further examination should be performed to understand other
factors that affection bacterial diversity and growth. The presence of highly antibiotic resistant
bacteria suggests that cooling towers are hot spots for genetic exchange. Additionally, the EPGs
used the same method as electroporation for gene transfer, thus further study should be
performed to evaluate if EPGs are facilitating the transfer of antibiotic resistance genes. Finally,
further testing should be performed to determine if one EPG device is more effective to reduce
the presence of antibiotic resistant bacteria.
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Appendixes
Appendix A: Antibiotic Zones of Inhibition
Becton, Dickinson and Company Zones of Inhibition (Becton Dickinson and Company, 2011)
*most resistant zones of inhibition are represented
Antibiotic

Abbreviation

Resistant

Intermediate

Susceptible

Zone of

Resistance Zone

Resistance

Inhibition

of Inhibition

Zone of

(mm)

(mm)

Inhibition (mm)

Amikacin

AN 30

≤14

15-16

≥17

Amoxicillin/

AmC 30

≤13

14-19

≥20

Ampicillin

AM 10

≤13

14-28

≥29

Carbenicillin

CB 100

≤19

20-22

≥29

Cefazolin

CZ 30

≤14

15-17

≥18

Cefepime

FEP 30

≤ 21

22-23

≥24

Cefixime

CFM 5

≤15

16-17

≥19

Cefoxitin

FOX 30

≤24

25-26

≥27

Ceftriaxone

CRO 30

≤24

25-26

≥27

Cephalothin

CF 30

≤14

15-17

≥18

Ciprofloxacin

CIP 5

≤27

28-40

≥41

Doxycycline

D 30

≤12

13-15

≥16

Imipenem

IPM 10

≤13

14-15

≥16

Levofloxacin

LVX 5

≤13

14-16

≥17

Lomefloxacin

LOM 10

≤26

27-37

≥38

Meropenem

MEM 10

≤13

14-15

≥16

Mezlocillin

MZ 75

≤17

18-20

≥21

Minocycline

MI 30

≤14

15-18

≥19

Clavulanic acid
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Appendix A Continued
Antibiotic

Abbreviation

Resistant

Intermediate

Susceptible

Zone of

Resistance Zone

Resistance

Inhibition

of Inhibition

Zone of

(mm)

(mm)

Inhibition (mm)

Oxacillin

OX 1

≤17

-

≥18

Piperacillin

PIP 100

≤17

18-20

≥21

Sulfadiazine

SD 0.25

≤10

11-14

≥15

Sulfamethoxazole/

SXT

≤15

16-18

≥19

Ticracillin

TIC 75

≤14

15-19

≥20

Tobramycin

NN 10

≤12

13-14

≥15

Trimethoprim
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Appendix B: Antibiotic chemical structures

Ceftriaxone (Edgar181, 2007)

Levofloxacin (Derksen, 2007)

Levofloxacin (Derksen, 2007)

Amikacin (Fvasconcellos, 2006)

Ampicillin (Mysid, 2007)

Ticarcillin (Fvasconcellos, 2006)
Amoxicillin/ Clavulanic acid (Fuse809, 2014)
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Doxycycline (Vaccinationist, 2017)

Sulfamethoxazole/ Trimethoprim (Vaccinationist, 2015)

Ciprofloxacin (Fvasconcellos, 2008)

Cefixime (JaGa, 2008)

Mezlocillin (Jü, 2017)
Lomefloxacin (Fvasconcellos, 2006)

Carbenicillin (Fvasconcellos, 2006)

Meropenem (Fvasconcellos, 2006)
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Tobramycin (Fvasconcellos, 2008)

Imipenem (Fvasconcellos, 2007)

Cefalotin (GNU, 2008)

Oxacillin (Fvasconcellos, 2007)

Piperacillin (Fvasconcellos, 2008)

Cefepime (Fuse809, 2014)

Sulfadiazine (public domain)
Minocycline (Fvasconcellos, 2011)
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Appendix C: Tukey’s HSD on HPC Samplers Summer Sampling. *Bold indicates significant
difference
Difference of Sample Levels

P-Value

7/6/2020 Bld 14 - 7/21/2020 Bld 14

0

7/6/2020 Bld 76 - 7/21/2020 Bld 14

0

7/6/2020 Bld 14 - 7/21/2020 Bld 76

0

7/6/2020 Bld 76 - 7/21/2020 Bld 76

0

8/25/2020 Bld 14 - 7/6/2020 Bld 14

0

8/25/2020 Bld 76 - 7/6/2020 Bld 14

0

8/3/2020 Bld 14 - 7/6/2020 Bld 14

0

8/3/2020 Bld 76 - 7/6/2020 Bld 14

0

9/22/2020 Bld 14 - 7/6/2020 Bld 14

0

9/22/2020 Bld 76 - 7/6/2020 Bld 14

0

9/8/2020 Bld 14 - 7/6/2020 Bld 14

0

9/8/2020 Bld 76 - 7/6/2020 Bld 14

0

8/25/2020 Bld 14 - 7/6/2020 Bld 76

0

8/25/2020 Bld 76 - 7/6/2020 Bld 76

0

8/3/2020 Bld 14 - 7/6/2020 Bld 76

0

8/3/2020 Bld 76 - 7/6/2020 Bld 76

0

9/22/2020 Bld 14 - 7/6/2020 Bld 76

0

9/22/2020 Bld 76 - 7/6/2020 Bld 76

0

9/8/2020 Bld 14 - 7/6/2020 Bld 76

0

9/8/2020 Bld 76 - 7/6/2020 Bld 76

0

8/3/2020 Bld 76 - 7/21/2020 Bld 76

0.002

8/25/2020 Bld 76 - 7/21/2020 Bld 76

0.011

9/22/2020 Bld 76 - 7/21/2020 Bld 76

0.018

9/8/2020 Bld 14 - 7/21/2020 Bld 76

0.018

8/25/2020 Bld 14 - 7/21/2020 Bld 76

0.049

7/21/2020 Bld 76 - 7/21/2020 Bld 14

0.091
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Appendix C Continued
Difference of Sample Levels

P-Value

9/22/2020 Bld 14 - 8/3/2020 Bld 76

0.096

9/8/2020 Bld 76 - 7/21/2020 Bld 76

0.109

8/3/2020 Bld 14 - 7/21/2020 Bld 76

0.22

9/22/2020 Bld 14 - 8/25/2020 Bld 76

0.316

9/22/2020 Bld 76 - 9/22/2020 Bld 14

0.402

9/8/2020 Bld 14 - 9/22/2020 Bld 14

0.404

9/22/2020 Bld 14 - 8/25/2020 Bld 14

0.639

9/22/2020 Bld 14 - 7/21/2020 Bld 14

0.789

9/8/2020 Bld 76 - 9/22/2020 Bld 14

0.829

8/3/2020 Bld 76 - 8/3/2020 Bld 14

0.889

9/22/2020 Bld 14 - 8/3/2020 Bld 14

0.947

9/8/2020 Bld 76 - 8/3/2020 Bld 76

0.972

9/22/2020 Bld 14 - 7/21/2020 Bld 76

0.979

8/3/2020 Bld 76 - 7/21/2020 Bld 14

0.982

8/3/2020 Bld 14 - 8/25/2020 Bld 76

0.994

8/3/2020 Bld 76 - 8/25/2020 Bld 14

0.997

9/22/2020 Bld 76 - 8/3/2020 Bld 14

0.998

9/8/2020 Bld 14 - 8/3/2020 Bld 14

0.998

8/25/2020 Bld 14 - 7/21/2020 Bld 14

1

8/25/2020 Bld 76 - 7/21/2020 Bld 14

1

8/3/2020 Bld 14 - 7/21/2020 Bld 14

1

9/22/2020 Bld 76 - 7/21/2020 Bld 14

1

9/8/2020 Bld 14 - 7/21/2020 Bld 14

1

9/8/2020 Bld 76 - 7/21/2020 Bld 14

1

7/6/2020 Bld 76 - 7/6/2020 Bld 14

1

8/25/2020 Bld 76 - 8/25/2020 Bld 14

1

8/3/2020 Bld 14 - 8/25/2020 Bld 14

1

9/22/2020 Bld 76 - 8/25/2020 Bld 14

1
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Appendix C Continued
Difference of Sample Levels

P-Value

9/8/2020 Bld 14 - 8/25/2020 Bld 14

1

9/8/2020 Bld 76 - 8/25/2020 Bld 14

1

8/3/2020 Bld 76 - 8/25/2020 Bld 76

1

9/22/2020 Bld 76 - 8/25/2020 Bld 76

1

9/8/2020 Bld 14 - 8/25/2020 Bld 76

1

9/8/2020 Bld 76 - 8/25/2020 Bld 76

1

9/8/2020 Bld 76 - 8/3/2020 Bld 14

1

9/22/2020 Bld 76 - 8/3/2020 Bld 76

1

9/8/2020 Bld 14 - 8/3/2020 Bld 76

1

9/8/2020 Bld 14 - 9/22/2020 Bld 76

1

9/8/2020 Bld 76 - 9/22/2020 Bld 76

1

9/8/2020 Bld 76 - 9/8/2020 Bld 14

1
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Appendix D: Bacteria Physical Descriptions
Designation

Description

3W

Beige/white translucent colony color, entire margin, 3 mm
White colony color, undulating edge with rings, flat with a raised center, 10

A

mm
Aggregates of yellow translucent pinhead-like colonies that resulted in an

AP

appearance of a dark yellow center and lighter edges in a gradient, 5 mm

B

White colony color, raised edge with sunken middle, 2 mm

BB

Blue/white colony color, irregular margin, 3mm

BBW

Beige colony color, flat, entire, 3-5mm
White colony color, circular edge, ringed, outer ring has a gradient to the

BC

edge, center solid with irregular bumps and dotted texture

BW

flat, white, 3-5 mm

BY

Big yellow colonies, entire, convex, 5 mm

C

White undulating bullseye, white gradient, dips into agar, 10 mm

CB

Beige, convex, 1 mm, opaque

CW

White, convex, entire, 1-4 mm

CY

Light yellow, highly convex with a height of 1 mm, entire margin, 1-10 mm
Light yellow, entire, convex, divot in center, like dy but lighter and without

DLY

lines, 4 mm
Opaque white irregular edge, wrinkly texture that grows upward, 2-3 mm up

DW

to 11 mm
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Appendix D Continued
Yellow, slight indent at center, entire, lines in the center that resemble an iris,
DY

4mm
Circular white center with translucent outer edge that undulates, looks like a

EGG

fried egg

F

White frosty colored, flat, 4-10 mm

FB

Murky white, flat, undulating, bullseye, flat, edge dry looking, 15 mm

FW

White, flat, 2 mm, entire, so flat looks level with the agar ring around edge

FY

Yellow, irregular edge, flat, uneven texture (like fruit leather), radial gradient

G

Greenish (yellow/blue), lowly convex, entire 1-4 mm

GB

Translucent green with a brown like inside, undulating edge
White translucent, irregular edge, textured with a bumpy appearance like
after pulling off a sticker with a gradient edge, middle is sunken edge is

GK

raised, irregular edge that is mostly entire with some undulations, 10-20 mm
Yellow, transparent/clear edge, yellow center and predominant color, can

H

grow in/on other colonies, 1-2 mm

IB

Beige, flat top, raised, entire edge, iridescent lines on top, 8 mm

IG

iridescent green

IRB

Beige, irregular edge, flat uneven texture, 7 mm

IW

White, irregular edge, wrinkly, 4 mm
White color, translucent light white irregular edge boundary, then a solid
white irregular ring around the edge, and a wormy/ brain like texture center,

IWA

20 mm
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Yellow beige, convex mostly entire, with some undulating and some
IY

iridescence in the center

J

Transparent/clear, elevated, bumps like warts irregularly placed on top, 5 mm
Beige, translucent, flat, textured with a bumpy appearance like after pulling
off a sticker, irregular edge that is mostly entire with some undulations, 10-

K

20 mm

L

White/beige, opaque, circular, fuzzy edge, ring pattern in center, 30 mm

LO

Opaque light orange, flat, 5 mm
White, entire, raised 1 mm above agar, slight indent in center, slightly

LW

wrinkled texture on surface, 4 mm

LY

Light yellow, raised, 1-5 mm

LYB

Yellow, raised ~1 mm, divot in center, 2 mm
White, with a white opaque circular center, undulating textured edges in an

M

oblong shape

N

Orange, flat, dry appearance, raise lip around edge, 12 mm

O

Orange, convex, <1 mm

P

Pinhead, translucent, <1 mm

PO

Pinhead orange, entire, <1 mm

PR

Pinhead red, entire, <1 mm

PY

Yellow pinhead, entire, <1 mm

R

Red, undulating, 5 mm
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RC

Red, entire, flat, 1.5 mm
Beige, translucent, flat, textured with a bumpy appearance like after pulling

RK

off a sticker, smooth textured undulating ring around the edge, 10-20 mm

RT

Red, translucent, entire, 1 mm
White colony, undulating center with an undulating ring around it, flat, 13

RU

mm

RW

White opaque, raised but with a flat top, entire, 3 mm
White colony with a wormy/brain texture and elevated ring around inner and

RWA

undulates, 8 mm

RY

Ringed yellow/white, raised, convex, entire, 2-5 mm

T

Transparent, flat, 1 mm

TB

Translucent yellow/brown, irregular edge, 3 mm, flat

TP

Translucent pink, entire, 1 mm
Transparent beige color, undulating edge, flat, textured like the “Sally
Hansen Fuzzy Coat Textured Nail Color” with short rods in the colony,

TU

40mm

TW

Transparent, wrinkly, irregular edge, 3 mm

TY

Translucent yellow, uneven circular edge

U

Beige, undulating, 32 mm

UB

White, undulating with a bullseye, raised, 10 mm

UF

White frosted, undulating, 6 mm
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Translucent white/beige, flat undulating edge, textured with a bumpy
appearance like after pulling off a sticker, smooth textured undulating ring
UK

around the edge, 24 mm

UT

Translucent, white middle, undulating edge

UW

White, undulating, flat, 8 mm

UY

Yellow, raised, irregular edge almost circular

VY

Yellow, highly convex, entire, 2mm

W

White, opaque, 1 mm
White, circular (not entire but almost) wiggly wormy/ brain like texture, flat,

WA

11mm

WB

Beige, wrinkly, entire, bullseye rings colony formation

WC

White, wrinkly/ undulating edge

WP

Light pink color, ring texture, 2 mm
White/opaque beige outer, solid white fuzzy inner, solid grey fuzzy center,

WW

convex, 1 mm

WY

White-yellow, raised with a flat top, 1-4 mm

Y

Yellow, opaque, raised, 1mm

YB

Yellow, entire with elevated rings (raised edge with sunken middle)

YL

Light yellow, translucent, lowly convex, entire, 4 mm
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Appendix E: Gram Stain Results of Isolated Bacteria from Cooling Tower Samples
Designation

Gram Stain

Bacteria

Notes

Shape

3W

Negative

bacillus

A

Negative

bacillus

AP

Negative

coccus

B

Positive

bacillus

in spindly rows

small and
clustered

BB

Negative

bacillus

BBW

Negative

bacillus

BC

Positive

bacillus

BW

Positive

coccus

BY

Negative

bacillus

C

Negative

bacillus

CB

Negative

bacillus

CW

Positive

coccus

CY

Negative

bacillus

DLY

Negative

coccus

DW

Negative

coccus

DY

Negative

bacillus

EGG

Positive

coccus

F

Positive

bacillus

FB

Positive

bacillus

FW

Positive

bacillus

FY

Negative

bacillus

G

Negative

coccus

in clumps

in strings

in lines
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Appendix E Continued
GB

Unable to isolate to gram stain

GK

Positive

bacillus

H

Negative

bacillus

IB

Positive

bacillus

IG

Negative

bacillus

IRB

Negative

bacillus

IW

Positive

bacillus

IWA

Positive

bacillus

IY

Positive

bacillus

J

Positive

coccus

K

Positive

coccus

L

Positive

bacillus

LO

Positive

coccus

LW

Positive

coccus

LY

Negative

bacillus

LYB

Negative

bacillus

M

Negative

coccus

N

Unable to isolate to gram stain

O

Negative

bacillus

P

Negative

coccus

PO

Unable to isolate to gram stain

PR

Unable to isolate to gram stain

PY

Negative

bacillus

R

Negative

coccus

in lines/ fibrous

small bacillus
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Appendix E Continued
RC

Negative

coccus

RK

Positive

bacillus

RT

Negative

coccus

RU

Negative

coccus

RW

Positive

coccus

RWA

Negative

bacillus

RY

Negative

bacillus

T

Negative

bacillus

TB

Positive

coccus

TP

Unable to isolate to gram stain

TU

Negative

coccus

TW

Negative

bacillus

TY

Negative

bacillus

U

Positive

bacillus

UB

Positive

coccus

UF

Negative

bacillus

UK

Positive

bacillus

UT

Negative

bacillus

UW

Positive

coccus

UY

Negative

bacillus

VY

Negative

bacillus

W

Negative

coccus

WA

Positive

coccus

WB

Negative

bacillus

in clusters

diplococci
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Appendix E Continued
WC

Positive

coccus

WP

Positive

bacillus

WW

Positive

coccus

WY

Negative

bacillus

Y

Negative

bacillus

YB

Negative

bacillus

YL

Negative

coccus
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Appendix F: Gram Stains and Bacteria Morphology of Bacteria Sequenced for their 16S rRNA
Gene

Figure S- 1: Gram stain of BW, Morganella morganii

Figure S- 2: Morphology of BW, Morganella morganii
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Figure S- 3: Gram stain of BY, Chryseobacterium ureilyticum

Figure S- 4: Morphology of BY, Chryseobacterium ureilyticum
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Figure S- 5: Gram stain of CW, Phenylobacterium sp.

Figure S- 6: Morphology of CW, Phenylobacterium sp.
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Figure S- 7: Gram stain of DY, Chryseobacterium cucumeris

Figure S- 8: Morphology of DY, Chryseobacterium cucumeris
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Figure S- 9: Gram stain of RY Stenotrophomonas maltophilia

Figure S- 10: Morphology of RY Stenotrophomonas maltophilia
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Figure S- 11: Gram stain of T, Bacillus licheniformis

Figure S- 12: Morphology of T, Bacillus licheniformis
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Figure S- 13: Gram stain of UK, Bacillus cereus

Figure S- 14: Morphology of UK, Bacillus cereus
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